Lexaria Bioscience Corp Stock Price on December 4, 2024
| LEXX Stock | USD 2.23 0.02 0.90% |
Below is the normalized historical share price chart for Lexaria Bioscience Corp extending back to October 10, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lexaria Bioscience stands at 2.23, as last reported on the 22nd of December, with the highest price reaching 2.24 and the lowest price hitting 2.15 during the day.
If you're considering investing in Lexaria Stock, it is important to understand the factors that can impact its price. Lexaria Bioscience Corp has Sharpe Ratio of -0.1, which conveys that the firm had a -0.1% return per unit of risk over the last 3 months. Lexaria Bioscience exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexaria Bioscience's Risk Adjusted Performance of (0.07), mean deviation of 3.06, and Standard Deviation of 4.34 to check out the risk estimate we provide.
At this time, Lexaria Bioscience's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 95.1 K in 2024, whereas Common Stock is likely to drop 8,839 in 2024. . At this time, Lexaria Bioscience's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 54.87 in 2024, whereas Price Earnings Ratio is likely to drop (61.55) in 2024. Lexaria Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of October 2006 | 200 Day MA 3.0024 | 50 Day MA 2.3966 | Beta 1.056 |
Lexaria |
Sharpe Ratio = -0.1029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LEXX |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lexaria Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lexaria Bioscience by adding Lexaria Bioscience to a well-diversified portfolio.
Price Book 4.8429 | Enterprise Value Ebitda (7.22) | Price Sales 94.6898 | Shares Float 13.2 M | Wall Street Target Price 10 |
Lexaria Bioscience Main Headline on 4th of December 2024
Lexaria Bioscience Corp. CEO Acquires 51,134.72 in Stock by thelincolnianonline.com
Lexaria Bioscience Corp. CEO Richard Christopher acquired 22,828 shares of Lexaria Bioscience stock in a transaction on Monday, December 2nd. The shares were bought at an average cost of 2.24 per share, with a total value of 51,134.72. Following the completion of the transaction, the chief executive officer now owns
Lexaria Bioscience Valuation on December 4, 2024
It is possible to determine the worth of Lexaria Bioscience on a given historical date. On December 4, 2024 Lexaria was worth 2.83 at the beginning of the trading date compared to the closed value of 2.59. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lexaria Bioscience stock. Still, in general, we apply an absolute valuation method to find Lexaria Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lexaria Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lexaria Bioscience's related companies.
| Open | High | Low | Close | Volume | |
| 2.30 | 2.70 | 2.29 | 2.70 | 430,633 | |
12/04/2024 | 2.83 | 2.85 | 2.43 | 2.59 | 271,685 |
| 2.61 | 2.61 | 2.27 | 2.34 | 304,783 |
| Backtest Lexaria Bioscience | | | Lexaria Bioscience History | | | Lexaria Bioscience Valuation | Previous | Next |
Lexaria Bioscience Trading Date Momentum on December 4, 2024
| On December 05 2024 Lexaria Bioscience Corp was traded for 2.34 at the closing time. The top price for the day was 2.61 and the lowest listed price was 2.27 . The trading volume for the day was 304.8 K. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 9.65% . The trading delta at closing time against the current closing price is 13.90% . |
Lexaria Bioscience Corp Fundamentals Correlations and Trends
By evaluating Lexaria Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lexaria financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lexaria Bioscience Stock history
Lexaria Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lexaria is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lexaria Bioscience Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lexaria Bioscience stock prices may prove useful in developing a viable investing in Lexaria Bioscience
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.4 M | 13 M | |
| Net Loss | -6.5 M | -6.9 M |
Lexaria Bioscience Quarterly Net Working Capital |
|
Lexaria Bioscience Stock Technical Analysis
Lexaria Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lexaria Bioscience Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Lexaria Bioscience Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lexaria Bioscience December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Lexaria Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lexaria Bioscience shares will generate the highest return on investment. By undertsting and applying Lexaria Bioscience stock market strength indicators, traders can identify Lexaria Bioscience Corp entry and exit signals to maximize returns
Lexaria Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lexaria Bioscience's price direction in advance. Along with the technical and fundamental analysis of Lexaria Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lexaria to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (2.96) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.